Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 78 results found. Search for [ COVAXIN human trial ]

Results 1 to 21 of 78
BusinessToday.In
November 23, 2020
The panel-led by Dravida Munnetra Kazhagam (DMK) lawmaker Kanimozhi Karunanidhi will hear officials of pharmaceutical departments on the status of the COVID-19 vaccine


BusinessToday.In
November 22, 2020
Bharat Biotech has started the phase- 3 trial of its potential COVID-19 vaccine, involving 26,000 volunteers this month across 25 centres in the country, including Hyderabad, Goa, Nagpur, Bhubaneswar, and Aligarh


Joe C Mathew
November 21, 2020
\"We expect emergency authorisation for Oxford-Astrazeneca vaccine to be sought in the UK. If so, it will give an opportunity for India regulator also (to consider such an option),\" says Dr Vinod Paul, chairman of the National Expert Group on Vaccine Administration for COVID-19


BusinessToday.In
November 21, 2020
Bharat Biotech, the developer of India's indigenous vaccine Covaxin, has said that it is planning to enrol about 2,000 participants each in metros for Phase-3 trials of its COVID-19 vaccine that began earlier this week


Reuters
November 17, 2020
The Hyderabad-based firm initiated phase I and phase II trials of its vaccine candidate after getting the green signal from the Drugs Controller General of India


BusinessToday.In
November 10, 2020
Sputnik V vaccine, developed by the Gamaleya National Research Institute of Epidemiology, was registered by the Russian Health Ministry


BusinessToday.In
November 4, 2020
COVID-19 vaccine update: Based on the success of the trials and regulatory approvals, we can expect vaccine to be available in India by January 2021, only if its proven immunogenic and efficacious, says SII CEO Adar Poonawalla


PB Jayakumar & Joe C Mathew
October 26, 2020
Zydus Cadila's COVID-19 candidate vaccine ZyCov-D, which is currently undergoing second phase of clinical trials in India, is likely to enter Phase III final stage of clinical trials by December 2020


BusinessToday.In
October 26, 2020
The outcome of immunogenicity blood tests conducted on a subgroup of older study participants echoed data published in July this year that revealed that the coronavirus vaccine produced robust immune responses in healthy adults aged 18-55 years


PTI
October 26, 2020
IMS and SUM Hospital is among the 21 medical institutes selected across the country by the Indian Council for Medical Research (ICMR) where the third phase trial would be conducted


PB Jayakumar | Joe C Mathew
October 25, 2020
Coronavirus vaccine administered through the intramuscular injection route protects the lower lungs but not the upper lung. Nasal vaccines can protect the lungs completely and stop transmission and also infection


BusinessToday.In
October 23, 2020
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is expected to be at least 60 per cent effective


BusinessToday.In
October 22, 2020
Covaxin, the COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has received the approval of Drugs Controller General of India (DCGI's) Expert Committee to start the final phase of trials


Rashi Bisaria
New Delhi, October 15, 2020
COVID-19 vaccine: Bharat Biotech fast-tracks Covaxin's trials, halves Phase 2 test sizeAs part of its effort to fast-track COVID-19 vaccine development, Hyderabad-based Bharat Biotech has cut the size of Phase 2 clinical trials of its indigenous coronavirus vaccine Covaxin by half. The vaccine, which Bharat Biotech is developing in collaboration with the country's apex medical research body - Indian Council of Medical Research (ICMR), will now be tested on 380 healthy volunteers in phase 2 a...


BusinessToday.In
October 14, 2020
Coronavirus vaccine update: Bharat Biotech is ready to start Covaxin's Phase 3 trail to test the vaccine on about 28,500 volunteers


BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


PTI
October 10, 2020
According to sources, the phase-2 trial of the Covaxin is going on and the second dose is yet to be given to volunteers at some sites


BusinessToday.In
October 2, 2020
Coronavirus cases in India: The active patients' tally in India stands at 9,42,217; around 53,52,078 patients have recovered and 99,773 have succumbed to the deadly virus so far


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


BusinessToday.In
September 15, 2020
COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief


PAGES 1 OF 4  1234